Is a complete ADIL research report available?

No complete published report is available for Adial Pharmaceuticals, Inc. (ADIL) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Adial Pharmaceuticals, Inc. (ADIL)

NASDAQ: ADIL · USD

$2.78

+0.10 (+3.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ADIL analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6M
Net income (ttm)	-7.8M
EPS (ttm)	-$8.22
Shares out	2.1M
Volume	38,011
Beta	1.43
Price target	$7.00	+151.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7.8M
EPS (ttm): -$8.22
Market cap: 6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ADIL indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001513525
Company name	Adial Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	00688A304
Employees	5
Employees Change	1%
Employees Change Percent	25
Enterprise value	$903,570
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2018-07-30
Isin	US00688A3041
Last refreshed	2026-07-25
Market cap	$6M
Market cap category	Nano-Cap
Price	$2.78
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	2834
Symbol	ADIL
Website	https://www.adial.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-141.6%
FCF yield	-118.8%
P/B ratio	1.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-7.8M
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Profit Per Employee	$-1.6M
ROA	-108.7
Roa5y	-108.9
ROCE	-202.7
ROE	-265.9
Roe5y	-304.3
ROIC	-161.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-76.79%
Cagr3y	-74.42%
Cagr5y	-71.56%
EPS Growth Quarters	7
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.2M
Cash	$4.6M
Current Assets	$4.8M
Current Liabilities	$1.5M
Debt	$0
Equity	$3.7M
Liabilities	$1.5M
Long Term Assets	$424,373
Long Term Liabilities	$0
Net Cash	$4.6M
Net Cash By Market Cap	$83.53
Net Cash Growth	93.77%
Net Debt Equity	$-1.23
Tangible Book Value	$3.7M
Tangible Book Value Per Share	$2.46
WACC	12.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.18
Net Working Capital	$-1.3M
Quick ratio	3.04
Working Capital	$3.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-311.35%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-76.77%
200-day SMA	4.32
3Y total return	-98.33%
50-day SMA	2.49
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.81%
All Time High	5,900
All Time High Change	-99.95%
All Time High Date	2019-01-15
All Time Low	1.31
All Time Low Change	112.21%
All Time Low Date	2026-05-15
ATR	0.22
Beta	1.43
Beta1y	1.85
Beta2y	1.36
Ch YTD	-49.45
High	2.78
High52	18.9
High52 Date	2025-07-29
High52ch	-85.29%
Low	2.5
Low52	1.31
Low52 Date	2026-05-15
Low52ch	112.21%
Ma50ch	11.69%
Premarket Change Percent	-0.76
Premarket Price	$2.66
Premarket Volume	438
Price vs 200-day SMA	-35.62%
RSI	55.54
RSI Monthly	32.35
RSI Weekly	41.99
Sharpe ratio	-1.19x
Sortino ratio	-1.7
Total Return	-311.35%
Tr YTD	-49.45
Tr1m	9.02%
Tr1w	-0.71%
Tr3m	78.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.94
Operating Income	$-7.5M
Price target	$7
Price Target Change	$152

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,403,822%
Float Percent	65.49%
Shares Insiders	3.6%
Shares Institutions	1.66%
Shares Out	2,143,621
Shares Qo Q	25.23%
Shares Yo Y	311.35%
Short Float	16.45%
Short Ratio	0.21
Short Shares	10.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.1M
Average Volume	37,794.25x
Bv Per Share	2.46
Ch1m	9.02
Ch1w	-0.71
Ch1y	-76.77
Ch3m	78.21
Ch3y	-98.33
Ch5y	-99.81
Ch6m	-51.97
Change	3.73%
Change From Open	4.51
Close	2.68
Days Gap	-0.75
Depreciation Amortization	565
Dollar Volume	105,670.6
Earnings Date	2026-08-12
Earnings Time	amc
EBIT	$-7.5M
EBITDA	$-7.5M
EPS	$-8.22
F Score	2
FCF	$-6.5M
FCF EV Yield	-721.54x
FCF Per Share	$-3.04
Financing CF	8,737,931
Fiscal Year End	December
Founded	2,010
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2026-02-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-05
Ma150	2.97
Ma150ch	-6.24%
Ma20	2.76
Ma20ch	0.91%
Net CF	2,218,320
Next Earnings Date	2026-08-12
Open	2.66
Optionable	No
Position In Range	100
Post Close	2.78
Postmarket Change Percent	-8.85
Postmarket Price	$2.53
Pre Close	2.68
Price Date	2026-07-24
Ptbv Ratio	1.48
Relative Volume	1.01x
Share Based Comp	587,369
Tr6m	-51.97%
Us State	Virginia
Volume	38,011

Adial Pharmaceuticals, Inc. (ADIL)

Coverage state: Market snapshot only — no published research

Generate the first ADIL analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ADIL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADIL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ADIL

Frequently asked questions